Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00104559
Status:
UNKNOWN
Last Update Posted:
2008-09-26
First Post:
2005-03-01
Brief Title:
Computer-Generated Vs Standard Informed Consent for HIV Research Studies
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Study Overview
Official Title:
Interactive Multimedia Informed Consent iMIC for HIV Research
Status:
UNKNOWN
Status Verified Date:
2008-09
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to test an interactive multimedia informed consent iMIC computer program to see if the program can generate a consent form that potential participants in an HIV trial can understand This study will also determine if these participants prefer the computer-generated consent form and associated interactive tools to a standard consent form written by researchers
Study hypothesis 1 Participants who receive information about clinical trials from iMIC Consent Tutorials will answer more questions about the trial correctly than participants who receive information about clinical trials from standard paper consent forms 2 Participants will rate the iMIC Consent Tutorials as having better usability and user satisfaction than standard paper consent forms
Study hypothesis 1 Participants who receive information about clinical trials from iMIC Consent Tutorials will answer more questions about the trial correctly than participants who receive information about clinical trials from standard paper consent forms 2 Participants will rate the iMIC Consent Tutorials as having better usability and user satisfaction than standard paper consent forms
Detailed Description:
Researchers conducting clinical trials have a legal and ethical obligation to provide participants key information about the trial so that they may either decline participation or grant their informed consent to participate in the study However information provided to prospective clinical trial participants is often complex and confusing often language used in informed consent is written far above participants reading level This study will evaluate the usefulness of a consent form authoring system that helps researchers write comprehensive and understandable consent forms the authoring system produces both paper consent forms and interactive computer tutorials that are designed to teach potential volunteers about the research study they are considering This study will compare iMIC-generated consent forms and computer tutorials with standard consent forms for two mock HIV studies a vaccine trial VT and an antiretroviral drug trial AT
The iMIC software provides researchers a computer-based authoring environment for producing easier-to-understand informed consent documents iMIC assists researchers by helping them focus on clearly defining consent issues and content goals including regulatory legal and ethical guidelines to be followed Through tests for readability and other feedback iMIC ensures that all the content requirements of good informed consent are met iMIC generates a paper consent form and an interactive multimedia computer tutorial to help volunteers learn about the clinical trial The paper consent document can be stand alone or used in conjunction with the generated computer tutorial
Each participant will receive two consent interventions one computer-based tutorial and one standard paper consent form Participants will be randomly assigned to one of four groups Group 1 will receive the computer-based tutorial for VT and then the standard paper consent form for AT Group 2 will receive the standard paper consent form for VT and then the computer-based tutorial for AT Group 3 will receive the computer-based tutorial for AT and then the standard paper consent form for VT Group 4 will receive the standard paper consent form for AT and then the computer-based tutorial for VT
At the start of the session participants will be asked demographic questions and will receive the first consent intervention When they have completed the intervention they will be asked 15 questions about the key elements of the clinical trial they have just learned about as well as an additional series of usability and satisfaction questions about the consent intervention Next they will receive the second consent intervention that will teach them about the second clinical trial Again they will be asked knowledge and usability and satisfaction questions After completing the second consent intervention participants will be asked to compare and answer questions about the two methods of receiving information about clinical trials
The iMIC software provides researchers a computer-based authoring environment for producing easier-to-understand informed consent documents iMIC assists researchers by helping them focus on clearly defining consent issues and content goals including regulatory legal and ethical guidelines to be followed Through tests for readability and other feedback iMIC ensures that all the content requirements of good informed consent are met iMIC generates a paper consent form and an interactive multimedia computer tutorial to help volunteers learn about the clinical trial The paper consent document can be stand alone or used in conjunction with the generated computer tutorial
Each participant will receive two consent interventions one computer-based tutorial and one standard paper consent form Participants will be randomly assigned to one of four groups Group 1 will receive the computer-based tutorial for VT and then the standard paper consent form for AT Group 2 will receive the standard paper consent form for VT and then the computer-based tutorial for AT Group 3 will receive the computer-based tutorial for AT and then the standard paper consent form for VT Group 4 will receive the standard paper consent form for AT and then the computer-based tutorial for VT
At the start of the session participants will be asked demographic questions and will receive the first consent intervention When they have completed the intervention they will be asked 15 questions about the key elements of the clinical trial they have just learned about as well as an additional series of usability and satisfaction questions about the consent intervention Next they will receive the second consent intervention that will teach them about the second clinical trial Again they will be asked knowledge and usability and satisfaction questions After completing the second consent intervention participants will be asked to compare and answer questions about the two methods of receiving information about clinical trials
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1R43AI058870-01 | NIH | None | httpsreporternihgovquickSearch1R43AI058870-01 |